Olivier Guisset Selected Research

Olivier Guisset Research Topics

5	Critical Illness (Critically Ill) 09/2021 - 12/2003
4	COVID-19 09/2021 - 11/2020
3	Septic Shock (Toxic Shock Syndrome) 04/2015 - 12/2003
2	Infections 03/2022 - 09/2021
2	Pneumonia (Pneumonitis) 09/2021 - 09/2013
2	Death (Near-Death Experience) 01/2020 - 01/2014
2	Respiratory Insufficiency (Respiratory Failure) 11/2017 - 02/2013
1	Neoplasms (Cancer) 03/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Glycosuria 06/2020
1	Proteinuria 06/2020
1	Albuminuria 06/2020
1	Pain (Aches) 01/2020
1	Hypercapnia 11/2017
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2016
1	Necrosis 04/2015
1	Measles 09/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2013
1	Acute Kidney Injury (Acute Renal Failure) 12/2003
1	Renal Insufficiency (Renal Failure) 12/2003
1	Bronchial Spasm 11/2002
1	Asthma (Bronchial Asthma) 11/2002

1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	beta-Lactamases (beta-Lactamase)IBA 03/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	CreatinineIBA 06/2020
1	Biological ProductsIBA 06/2020
1	Proteins (Proteins, Gene)FDA Link 06/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 04/2017
1	Chemokine ReceptorsIBA 04/2016
1	plerixafor FDA Link 04/2016
1	CaspasesIBA 04/2015
1	Histones (Histone)IBA 04/2015
1	Neuromuscular Blocking AgentsIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2007
1	ProcalcitoninIBA 12/2003
1	Nylons (Nylon)IBA 12/2003
1	Methacholine Chloride (Methacholine)FDA Link 11/2002
1	Albuterol (Salbutamol)FDA LinkGeneric 11/2002

4	Critical Care (Surgical Intensive Care) 01/2021 - 02/2013
4	Artificial Respiration (Mechanical Ventilation) 01/2020 - 09/2013
2	Noninvasive Ventilation 11/2017 - 02/2013
1	Therapeutics 03/2022
1	Injections 09/2013
1	Continuous Renal Replacement Therapy 12/2003
1	Hemofiltration 12/2003